Crystalline N-{(1 S)-2-amino-1-[(3fluorophenyl)methyl]ethyl}-5-chloro-4-(4 -chloro-1-methyl-1 H-pyrazol-5-yl)-2thiophenecarboxamide hydrochloride

Details for Australian Patent Application No. 2010208265 (hide)

Owner GlaxoSmithKline LLC

Inventors Chen, Pingyun Y.; Gaulding, Jeffrey

Agent Davies Collison Cave

Pub. Number AU-A-2010208265

PCT Pub. Number WO2010/088331

Priority 61/148,490 30.01.09 US

Filing date 28 January 2010

Wipo publication date 5 August 2010

International Classifications

A61K 31/381 (2006.01) - having five-membered rings

Event Publications

4 August 2011 PCT application entered the National Phase

  PCT publication WO2010/088331 Priority application(s): WO2010/088331

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010208270-Solid oral formulations of a pyridopyrimidinone

2010208258-Channel specific gain control including lateral suppression